Karolina Madela

442 total citations
8 papers, 192 citations indexed

About

Karolina Madela is a scholar working on Infectious Diseases, Hepatology and Molecular Biology. According to data from OpenAlex, Karolina Madela has authored 8 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Hepatology and 4 papers in Molecular Biology. Recurrent topics in Karolina Madela's work include Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (7 papers) and Hepatitis B Virus Studies (4 papers). Karolina Madela is often cited by papers focused on Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (7 papers) and Hepatitis B Virus Studies (4 papers). Karolina Madela collaborates with scholars based in United Kingdom, Belgium and United States. Karolina Madela's co-authors include Christopher McGuigan, Johan Neyts, Michaela Serpi, Alexander A. Kolykhalov, Stanley D. Chamberlain, John Vernachio, Magdalena Ślusarczyk, Fabrizio Pertusati, Andrea Hall and Jeff Hutchins and has published in prestigious journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Antiviral Research.

In The Last Decade

Karolina Madela

7 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karolina Madela United Kingdom 6 129 109 68 63 37 8 192
David Dukhan France 8 140 1.1× 134 1.2× 153 2.3× 185 2.9× 88 2.4× 17 339
Sanjib Bera United States 9 165 1.3× 156 1.4× 82 1.2× 61 1.0× 114 3.1× 19 281
Keith Pietropaolo United States 12 211 1.6× 67 0.6× 194 2.9× 190 3.0× 34 0.9× 33 370
Kanda S. Ramasamy United States 13 102 0.8× 323 3.0× 62 0.9× 66 1.0× 152 4.1× 25 463
Erika Cretton-Scott United States 8 234 1.8× 125 1.1× 209 3.1× 207 3.3× 46 1.2× 10 423
Abdesslem Faraj France 10 203 1.6× 188 1.7× 129 1.9× 177 2.8× 152 4.1× 19 443
Danuta Madej Canada 8 153 1.2× 202 1.9× 69 1.0× 157 2.5× 157 4.2× 10 414
Dmitry V. Yanvarev Russia 11 111 0.9× 164 1.5× 19 0.3× 72 1.1× 74 2.0× 31 327
Oliver L. Saunders United States 5 180 1.4× 78 0.7× 17 0.3× 55 0.9× 48 1.3× 6 254
Carlo Boutton Belgium 7 57 0.4× 102 0.9× 70 1.0× 47 0.7× 69 1.9× 9 232

Countries citing papers authored by Karolina Madela

Since Specialization
Citations

This map shows the geographic impact of Karolina Madela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolina Madela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolina Madela more than expected).

Fields of papers citing papers by Karolina Madela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolina Madela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolina Madela. The network helps show where Karolina Madela may publish in the future.

Co-authorship network of co-authors of Karolina Madela

This figure shows the co-authorship network connecting the top 25 collaborators of Karolina Madela. A scholar is included among the top collaborators of Karolina Madela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karolina Madela. Karolina Madela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
McGuigan, Christopher, Marco Derudas, Nadège Hamon, et al.. (2013). Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides. European Journal of Medicinal Chemistry. 70. 326–340. 25 indexed citations
2.
Serpi, Michaela, Karolina Madela, Fabrizio Pertusati, & Magdalena Ślusarczyk. (2013). Synthesis of Phosphoramidate Prodrugs: ProTide Approach. Current Protocols in Nucleic Acid Chemistry. 53(1). 15.5.1–15.5.15. 22 indexed citations
3.
Madela, Karolina & Christopher McGuigan. (2012). Progress In The Development Of Anti-Hepatitis C Virus Nucleoside And Nucleotide Prodrugs. Future Medicinal Chemistry. 4(5). 625–650. 22 indexed citations
4.
McGuigan, Christopher, Karolina Madela, Arnaud Gilles, et al.. (2011). Dual pro-drugs of 2′-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 21(19). 6007–6012. 14 indexed citations
5.
Hutchins, Jeff, Christopher McGuigan, Stanley D. Chamberlain, et al.. (2011). DMPK and Metabolism Studies of Nucleoside Phosphoramidates Including INX-08189, A Novel Double Pro-drug and Clinical Candidate for Hepatitis C Virus Therapy. Antiviral Research. 90(2). A22–A23. 1 indexed citations
6.
McGuigan, Christopher, Karolina Madela, Arnaud Gilles, et al.. (2010). Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 20(16). 4850–4854. 73 indexed citations
7.
McGuigan, Christopher, et al.. (2009). The phosphoramidate ProTide approach greatly enhances the activity of β-2′-C-methylguanosine against hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 19(15). 4316–4320. 33 indexed citations
8.
Hutchins, J., Chia‐Chi Chang, Elena Gorovits, et al.. (2009). In Vitro Activity and In Vivo Pharmacokinetics of Highly Potent Phosphoramidate Nucleoside Analogue Inhibitors of Hepatitis C NS5B. Antiviral Research. 82(2). A28–A28. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026